Trials / Unknown
UnknownNCT02177708
Quantitative Determination of Brain Water Content in Patients During and After Hepatic Encepalopathy
Quantitative Determination of Brain Water Content in Patients During and After Hepatic Encepalopathy Measured by MR
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 45 (estimated)
- Sponsor
- University of Aarhus · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
There is increasing evidence that the pathophysiology of hepatic encephalopathy (HE) is tightly associated with low-grade cerebral edema. Uptake of ammonia in astrocytes leads to osmotic swelling caused by glutamine formation. Previous studies were performed in covert HE patients or used indirect methods. Methods: The investigators wish to describes quantitative measurement of localized water content using MRI water mapping in a cohort of patients with cirrhosis during an episode of overt HE type C and again after recovery. Furthermore patients with cirrhosis and no history of HE and healthy subjects will be investigated as controls.
Conditions
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2015-06-01
- Completion
- 2015-12-01
- First posted
- 2014-06-30
- Last updated
- 2014-06-30
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02177708. Inclusion in this directory is not an endorsement.